A detailed history of Koss Olinger Consulting, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Koss Olinger Consulting, LLC holds 20,592 shares of MDT stock, worth $1.87 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
20,592
Previous 21,874 5.86%
Holding current value
$1.87 Million
Previous $1.72 Million 7.67%
% of portfolio
0.16%
Previous 0.16%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$76.84 - $91.03 $98,508 - $116,700
-1,282 Reduced 5.86%
20,592 $1.85 Million
Q2 2024

Aug 06, 2024

BUY
$78.71 - $87.02 $1.72 Million - $1.9 Million
21,874 New
21,874 $1.72 Million
Q4 2023

Feb 13, 2024

SELL
$69.43 - $83.43 $20,759 - $24,945
-299 Reduced 1.29%
22,969 $1.89 Million
Q3 2023

Oct 10, 2023

BUY
$78.22 - $90.4 $15,018 - $17,356
192 Added 0.83%
23,268 $1.82 Million
Q2 2023

Jul 28, 2023

BUY
$79.47 - $91.38 $21,218 - $24,398
267 Added 1.17%
23,076 $2.03 Million
Q1 2023

May 12, 2023

BUY
$76.72 - $87.58 $117,918 - $134,610
1,537 Added 7.23%
22,809 $1.84 Million
Q4 2022

Feb 13, 2023

BUY
$76.18 - $87.74 $1.1 Million - $1.27 Million
14,483 Added 213.33%
21,272 $1.65 Million
Q3 2022

Nov 14, 2022

BUY
$80.75 - $95.31 $548,211 - $647,059
6,789 New
6,789 $548,000
Q2 2022

Jul 08, 2022

SELL
$87.4 - $113.09 $247,604 - $320,383
-2,833 Closed
0 $0
Q1 2022

May 06, 2022

BUY
$100.58 - $112.38 $42,645 - $47,649
424 Added 17.6%
2,833 $314,000
Q4 2021

Feb 07, 2022

SELL
$99.53 - $127.75 $64,395 - $82,654
-647 Reduced 21.17%
2,409 $249,000
Q3 2021

Nov 09, 2021

BUY
$122.75 - $135.17 $159,084 - $175,180
1,296 Added 73.64%
3,056 $383,000
Q2 2021

Aug 11, 2021

BUY
$118.19 - $131.5 $208,014 - $231,440
1,760 New
1,760 $218,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $121B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Koss Olinger Consulting, LLC Portfolio

Follow Koss Olinger Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koss Olinger Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Koss Olinger Consulting, LLC with notifications on news.